Overview

Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study will compare the safety and efficacy of initial combination treatment with aliskiren + amlodipine to sequential add-on treatment strategies with aliskiren or amlodipine in patients with hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Calcium Channel Blockers
Hydrochlorothiazide